Immunome, Inc.

NASDAQ:IMNM

Biotechnology

Healthcare
$16.61 -2.26%

-$0.42 today

Market cap
$1.96B
Beta
2.07
P/E (TTM)
-9.1
EPS (TTM)
-$1.99
52W Low $7.96High $27.65

Volume 0.88M

Average 1.23M

Balance Sheet

Inspect the capital base behind the business.

Assets

$683.19M

FY 2025 · Annual

+184.4% YoY

Liabilities

$48.84M

FY 2025 · Annual

-17.3% YoY

Equity

$634.34M

FY 2025 · Annual

+250.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents49.23M20.32M98.68M143.35M653.48M
Short-term Investments0039.46M73.95M0
Net Receivables4.31M847K289K00
Inventory00000
Other Current Assets004.99M4.04M7.3M
Total Current Assets56.64M22.65M144.7M221.34M660.78M
Property, Plant & Equipment (Net)855K965K3.64M14.39M17.61M
Goodwill00000
Intangible Assets00000
Long-term Investments100K0100K0210K
Tax Assets00000
Other Non-current Assets332K432K100K4.51M4.59M
Total Non-current Assets1.29M1.4M3.84M18.9M22.41M
Total Assets57.93M24.05M148.54M240.24M683.19M
Account Payables3.08M2.4M3.31M14.19M3.34M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0010.49M6.94M0
Other Current Liabilities2.02M1.96M4.98M8M15.15M
Total Current Liabilities9.73M7.33M21.83M54.31M44.99M
Long-term Debt00003.86M
Deferred Tax Liabilities00(5.49M)00
Deferred Revenue (Non-current)005.49M00
Other Non-current Liabilities12K05.49M00
Total Non-current Liabilities12K62K6.83M4.77M3.86M
Total Liabilities9.74M7.39M28.66M59.08M48.85M
Common Stock1K1K4K6K11K
Retained Earnings(79.11M)(116M)(222.81M)(515.77M)(728.16M)
Accumulated OCI(57.93M)022K57K0
Other Stockholders Equity00000
Minority Interest00000
Total Equity48.19M16.65M119.88M181.17M634.34M
Total Debt317K291K1.65M4.83M3.86M
Net Debt(48.91M)(20.03M)(97.03M)(138.52M)(649.63M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$212.8M
Short-term Investments$248.7M
Other Current$16.2M
Total Current Assets$477.8M
PP&E (Net)$20.6M
Other Non-current$7.2M
Total Non-current Assets$27.7M
Total Assets$505.5M

Analysis

Selected assets total $505.5M for Latest. The largest visible component is Short-term Investments at $248.7M, about 49.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-3ASRS-3ASR filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
S-3ASRS-3ASR filingNov 9, 2026
SC 13GSC 13G filingOct 30, 2026

How much cash does IMNM have?

Immunome, Inc. (IMNM) reported $653.48M in cash and equivalents in fiscal 2025.

How much debt does IMNM carry?

Immunome, Inc. (IMNM) reported $3.85M of total debt, with net debt of -$649.63M.